Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 14/12/2023.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques fabriquées localement :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | PSODERM PLUS | CALCIPOTRIOL+BETAMETHASONE | 50 mcg/0.5mg/gr | Pommade dermique | FL/60 g | PHARMAGHREB | E | N | 01/11/2023 |
2 | CLARIREC | CLARITHROMYCINE | 500 MG | Comprimé pelliculé s | B/14 | OPALIA PHARMA | E | N | 11/11/2023 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | POLAR | OLANZAPINE | 5 mg | Comprimé pelliculé sécable | B/10 | SAIPH | E | N | 24/10/2023 |
2 | SOLFICINE | SOLIFENACINE SUCCINATE | 5 mg | Comprimé pelliculé | B/30 | PHARMAGHREB | E | N | 03/11/2023 |
3 | SOLFICINE | SOLIFENACINE SUCCINATE | 10 mg | Comprimé pelliculé | B/30 | PHARMAGHREB | E | N | 03/11/2023 |
4 | URICARE | SOLIFENACINE SUCCINATE | 5 mg | Comprimé pelliculé | B/30 | TAHA PHARMA | E | N | 03/11/2023 |
5 | URICARE | SOLIFENACINE SUCCINATE | 10 mg | Comprimé pelliculé | B/30 | TAHA PHARMA | E | N | 03/11/2023 |
6 | CARDIOCINE | ACIDE ACETYLSALICYLIQUE | 160 mg | Comprimé sécable | B/30 | ACT PHARMA | E | N | 03/11/2023 |
7 | ALFACAPS | ALFACALCIDOL | 0,25 ug | Capsule molle | B/30 | SAIPH | E | N | 12/11/2023 |
8 | ADONTAG | PREGABALINE | 50 mg | Gélule | B/84 | TAHA PHARMA | V | N | 12/12/2023 |
9 | BECLONIL | BECLOMETASONE | 50 µg | SOL PR INH | B/1 FL/200 doses | VAGA LABORATORIES | N | 12/12/2023 | |
10 | BI-GALVINE | VILDAGLIPTINE | 50 mg/850 mg | Comprimé | B/30 | SAIPH | E | N | 12/12/2023 |
11 | FUXINE | FUCIDATE DE SODIUM | 250 MG | Comprimé pelliculé | B/10 | SAIPH | E | N | 12/12/2023 |
12 | FUXINE | FUCIDATE DE SODIUM | 250 MG | Comprimé pelliculé | B/20 | SAIPH | E | N | 12/12/2023 |
13 | FUXINE | FUCIDATE DE SODIUM | 250 MG | Comprimé pelliculé | B/30 | SAIPH | E | N | 12/12/2023 |
14 | INIPLAC | TICAGRELOR | 90 mg | Comprimé pelliculé | B/60 | GALPHARMA | E | N | 12/12/2023 |
15 | TEMOZOLOMIDE NEAPOLIS | TÉMOZOLOMIDE | 100 mg | PDRE PR SOL PF | B/1FL | NEAPOLIS PHARMA | E | N | 12/12/2023 |
16 | TREPARIN | SULODEXIDE | 250 ULS | Capsule molle | B/30 | SAIPH | I | N | 12/12/2023 |
17 | TREPARIN | SULODEXIDE | 250 ULS | Capsule molle | B/60 | SAIPH | I | N | 12/12/2023 |
18 | VILDUS | VILDAGLIPTINE | 50 mg | comprimé | B/30 | OPALIA PHARMA | E | N | 12/12/2023 |
Spécialités Pharmaceutiques importées
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | CRESEMBA | ISAVUCONAZOLE | 100 MG | GEL | B/14 | HIKMA Pharmaceuticals | N | 11/07/2023 | |
2 | ERLEADA | APALUTAMIDE | 60 mg | COMP PEL | B/112 | Janssen-Cilag International N.V | N | 14/11/2023 | |
3 | OPSUMIT | MACITENTAN | 10 mg | COMP PEL | B/30 | Janssen-Cilag International N.V | N | 20/11/2023 | |
4 | UPTRAVI | SELEXIPAG | 200 mcg | COMP PEL | B/140 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
5 | UPTRAVI | SELEXIPAG | 200 mcg | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
6 | UPTRAVI | SELEXIPAG | 400 mcg | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
7 | UPTRAVI | SELEXIPAG | 600 mcg | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
8 | UPTRAVI | SELEXIPAG | 800 mcg | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
9 | UPTRAVI | SELEXIPAG | 1000 mcg | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
10 | UPTRAVI | SELEXIPAG | 1200 mcg | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
11 | UPTRAVI | SELEXIPAG | 1400 mcg | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
12 | UPTRAVI | SELEXIPAG | 1600 mcg | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 20/11/2023 |
13 | ENSPRYNG | SATRALIZUMAB | 120 mg/1 ml | SOL INJ | B/1 seringue pré-remplie de 1ml | Roche Pharma (Schweiz) AG | N | 22/11/2023 | |
14 | KALINOR - retard P | CHLORURE DE POTASSIUM | 600 mg | GEL | B/50 | DESMA GmbH | N | 22/11/2023 | |
15 | POVIDEX | POVIDONE IODEE | 5% | SUPPO VAGINAL | B/12 | BEIT JALA Pharmaceutical Co | I | N | 12/06/2023 |
16 | MYCOTEN | CLOTRIMAZOLE | 200 mg | COMP GYN | B/3 avec applicateurs | BEIT JALA Pharmaceutical Co | I | N | 12/11/2023 |
17 | MYCOTEN VAGINAL CREAM | CLOTRIMAZOLE | 2% | CREM VAGINAL | T/20g | BEIT JALA Pharmaceutical Co | I | N | 12/11/2023 |
18 | MYCOTEN | CLOTRIMAZOLE | 500 mg | COMP GYN | B/1 Comprimé + Applicateur | BEIT JALA Pharmaceutical Co | I | N | 12/11/2023 |
19 | EVRYSDI | RISDIPLAM | 0.75 mg/ml | PDRE PR SOL ORAL | FL/100 ml | Roche Pharma (Schweiz) AG | N | 11/12/2023 | |
20 | KADCYLA | TRASTUZUMAB | 160 MG | PDRE PR SOL SOL PR PF | B/1FL /20ml (160mg de poudre) | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | N | 11/12/2023 | |
21 | KADCYLA | TRASTUZUMAB | 100 MG | PDRE PR SOL SOL PR PF | B/1FL /20ml (160mg de poudre) | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | N | 11/12/2023 |
* Produits à évaluer pour la première fois au Comité Technique
Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE | |
1 | BENEFIX | FACTEUR IX | 250 UI | PDRE PR PREP INJ | B/1 FL+ ser/5ml+kit de transfert | PFIZER Europe MA EEIG | V | T | 06/10/2023 |
2 | BENEFIX | FACTEUR IX | 500 UI | PDRE PR PREP INJ | B/1 FL+ ser/5ml+kit de transfert | PFIZER Europe MA EEIG | V | T | 06/10/2023 |
3 | BENEFIX | FACTEUR IX | 1000 UI | PDRE PR PREP INJ | B/1 FL+ ser/5ml+kit de transfert | PFIZER Europe MA EEIG | V | T | 06/10/2023 |
4 | LYNPARZA | OLAPARIB | 150 mg | COMP PEL | B/56 | AstraZeneca AB SUEDE | N | 11/03/2023 | |
5 | LYNPARZA | OLAPARIB | 100 mg | COMP PEL | B/56 | AstraZeneca AB SUEDE | N | 11/03/2023 | |
6 | SEMGLEE | INSULINE GLARGINE | 100 UI/ml | SOL INJ | B/5 stylos pré-remplis | Biosimilar Collaborations Ireland Limited ("BCIl") | V | T | 17/10/2023 |
7 | MYCOSTER VERNIS | CICLOPIROXOLAMINE | 8% | SOL EXTERNE | FL/3ML | PIERRE FABRE MEDICAMENT . | E | T | 26/10/2023 |
8 | MYCOSTER | CICLOPIROXOLAMINE | 1% | PDRE A USAGE EXTERNE | FL/30 GR | PIERRE FABRE MEDICAMENT . | E | T | 26/10/2023 |
9 | ABSTRAL | FENTANYL | 100 µg | COMP SUBL | B/10 | KYOWA KIRIN INC | V | N | 03/11/2023 |
10 | ABSTRAL | FENTANYL | 200 µg | COMP SUBL | B/10 | KYOWA KIRIN INC | V | N | 03/11/2023 |
11 | REMSIMA SC | INFLIXIMAB | 120 mg | SOL INJ | B/2seringues prérempli | HIKMA Pharmaceuticals | E | N | 08/11/2023 |
12 | REMSIMA SC | INFLIXIMAB | 120 mg | SOL INJ | B/2 Stylos prérempli | HIKMA Pharmaceuticals | E | N | 08/11/2023 |
13 | REMSIMA SC | INFLIXIMAB | 120 mg | SOL INJ | B/1seringues préremplies | HIKMA Pharmaceuticals | E | N | 08/11/2023 |
14 | REMSIMA SC | INFLIXIMAB | 120 mg | SOL INJ | B/4 Stylos préremplis | HIKMA Pharmaceuticals | E | N | 08/11/2023 |
15 | REMSIMA SC | INFLIXIMAB | 120 mg | SOL INJ | B/4 seringues préremplies | HIKMA Pharmaceuticals | E | N | 08/11/2023 |
16 | REMSIMA SC | INFLIXIMAB | 120 mg | SOL INJ | B/1 stylo prérempli | HIKMA Pharmaceuticals | E | N | 08/11/2023 |
15 | OLMESATAN MEDOXOMIL & AMLODIPINE /GENEPHARM | AMLODIPINE+OLMESARTAN MEDOXOMIL | 40 mg/5mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 12/12/2023 |
16 | OLMESATAN MEDOXOMIL & AMLODIPINE /GENEPHARM | AMLODIPINE+ OLMESARTAN MEDOXOMIL | 20 mg/5mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 12/12/2023 |
17 | OLMESATAN MEDOXOMIL & AMLODIPINE /GENEPHARM | AMLODIPINE+ OLMESARTAN MEDOXOMIL | 40 mg/10mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 12/12/2023 |
18 | CARDENSIEL | BISOPROLOL | 1.25 mg | COMP PEL | B/30 | Merck Santé s.a.s | E | N | 12/12/2023 |
* AMM à supprimer
N° | Date | N° AMM | Libellé | DCI | Titulaire |
1 | 17/12/2020 | 6063125H | Navelbine inj 10 MG B/1 | Vinrelbine | Pierre Fabre France |
2 | 17/12/2020 | 6063126H | Navelbine inj 50 MG B/1 | Vinrelbine | Pierre Fabre France |
6 | 07/01/2022 | N6041 | ZEMTRON 8 MG CP**** | Hikma | |
7 | 15/07/2022 | 15273021 | Zytiga 250 mg cp pell B120 | Abiraterone | Janssen |
8 | 22/12/2022 | 1923022H | Simponi 50 mg Sol Inj en SERINGUE Pré-REMPLIE b/1 | golimumab | Jannsen biologics BV BELGIQUE |
9 | 10/01/2023 | 5103074 | ATACAND 4 mg Comp Sécable B/30 | CANDESARTAN | ASTRA ZENECA France |
10 | 19/01/2023 | 10493021 | THIOBACIN 500 mg CP Enrobé B/24 | THIAMPHENICOL | Sanofi Aventis Maroc |
11 | 19/01/2023 | 6390071B | NIVAQUINE 100 MG Cp Séc B/100 | CHLOROQUINE | SANOFI AVENTIS France |
12 | 19/01/2023 | ST9263022 | DOGMATIL 0.5% Sol Buv FL/200 ml | Sulpiride | Sanofi Aventis PHARMA Tunisie |
13 | 23/01/2023 | 18583011 | COSOPT COLLYRE FL/5ML | TIMOLOL+DORZOLAMIDE | Mundipharma pty LTD Australie |
14 | 30/01/2023 | 6943081H | ETOPOSIDE EBEWE 100 MG IN FL 5 ML | ETOPOSIDE | |
15 | 30/01/2023 | 6943111H | EPIRUBICINE EBEWE 2 MG/ML INJ FL/5ML | EPIRUBICINE | EBEWE PHARMA Gmbh |
16 | 30/01/2023 | 6943112H | EPIRUBICINE EBEWE 2 MG/ML INJ FL/25ML | EPIRUBICINE | EBEWE PHARMA Gmbh |
17 | 30/01/2023 | 6943121H | EBETAXEL 30 mg SOLP FLAC B/1FL/5 ml | PACLITAXEL | EBEWE PHARMA Gmbh |
18 | 30/01/2023 | 6943131H | EBETAXEL 100 mg SOLP FLAC B/1FL/16.7 ml | PACLITAXEL | EBEWE PHARMA Gmbh |
19 | 30/01/2023 | 6943132H | EBETAXEL 150 mg SOLP FLAC B/1FL/25 ml | PACLITAXEL | EBEWE PHARMA Gmbh |
20 | 30/01/2023 | 6943171H | EBEDOCE 20 MG/2ML SOL P PERF | DOCETAXEL | EBEWE PHARMA Gmbh |
21 | 30/01/2023 | 6943172H | EBEDOCE 80 MG/8ML SOL P PERF | DOCETAXEL | EBEWE PHARMA Gmbh |
22 | 16/02/2023 | 6000031 | praxilene 100 mg Glule B/20 | Naftidrofuryl | Merck SAS FRANCE |
23 | 17/02/2023 | 6000033 | praxilene 200 mg Glule B/20 | Naftidrofuryl | Merck SAS FRANCE |
25 | 17/02/2023 | 14293021H | EPIVIR 10 mg/ml SOOR FL/240 ml | Lamivudine | VIV HELTHCARE UK LTD |
26 | 17/02/2023 | 23013011H | RETROVIR 100 mg Gel B/100 | Zidovudine | VIV HELTHCARE BV PAYS BAS |
27 | 17/02/2023 | 23013021H | EPIVIR 150 mg COPE FL/60 | Lamivudine | VIV HELTHCARE BV PAYS BAS |
28 | 17/02/2023 | 23013041H | Ziagen 300 mg Comp B/60 | ABACAVIR | VIV HELTHCARE BV PAYS BAS |
24 | 17/02/2023 | 7063101 | INFANRIX IPV HIB PPINJ B/1FL+SER PRE REMPLIE | VACCIN DTCP HIB | GSK BILOGICS Belgique |
29 | 27/02/2023 | 1233011H | KETAMINE PANPHARMA 250 mg/5 ml B/25 AMP | Ketamine | Panpharma Allemagne |
31 | 15/03/2023 | 6060031H | DOPAMINE50 Mg Sol INJ B/50/10 ML | DOPAMINE | Pierre Fabre France |
30 | 15/03/2023 | 6060015 | CYCLO 3 FORT AP BUV B/30/5 ML | extrait de russcus | Pierre Fabre France |
32 | 23/03/2023 | 6943022H | METHOTREXATE EBEWE 500 mg inj | METHOTREXATE | EBEWE PHARMA Gmbh |
33 | 23/03/2023 | 6943031H | Calcium folinat Ebewe 30 MG Ampoules | Folinate de calcium | EBEWE PHARMA Gmbh |
34 | 23/03/2023 | 6943041H | CISPLATINE Ebewe 25 mg injectable B/5 | CISPLATINE | EBEWE PHARMA Gmbh |
35 | 23/03/2023 | 6943091H | 5 fluorouracxil EBEWE 250 mg Amp B/5 | 5-Fluorouracile | EBEWE PHARMA Gmbh |
36 | 13/04/2023 | 6533062 | Dalacin Topic | Pristinamycine | Pfizer Holding France |
37 | 13/04/2023 | ST9243121 | Solu medol 20 mg inj | Methylprednisolone | Pfizer Tunisie |
38 | 25/04/2023 | 6513041 | xyzall cp B/14 | Levocetirizine | UCB France |
41 | 10/05/2023 | 6593011A | Danatrol 200 mg gel B/40 | Sanofi Aventis FRANCE | |
39 | 10/05/2023 | 6113044 | oroken enfants | Ccefixime | SANOFI AVENTIS France |
40 | 10/05/2023 | 6113045 | oroken NRS | Ccefixime | SANOFI AVENTIS France |
42 | 10/05/2023 | 8613011H | Granocyte 34 mui/ml PPInj B/5 FL | LINOGRASTIM | Sanofi AB Suède |
43 | 11/05/2023 | 11073071 | Repaglinid Sandoz 0.5 mg b90 | Repaglinid | Sandoz GMBH |
44 | 12/05/2023 | 11073072 | Repaglinid Sandoz 1 mg b90 | Repaglinid | Sandoz GMBH |
45 | 13/05/2023 | 11073073 | Repaglinid Sandoz 2 mg b90 | Repaglinid | Sandoz GMBH |
46 | 14/05/2023 | 11073061 | Venlafaxin Sandoz 150 mg GEL lp b30 | Venlafaxine | Sandoz GMBH |
47 | 31/05/2023 | 21313011 | Betoptic 0.5% Collyre FL/5 ml | Betaxolol | Novartis Pharma NV |
53 | 08/06/2023 | 6883371 | Oligostim Soufre 15µg cp | souches homéopathiques | Boiron-France |
54 | 08/06/2023 | 6883351 | Oligostim Zinc 32 µg cp | souches homéopathiques | Boiron-France |
55 | 08/06/2023 | 6883281 | Oligostim Zinc Cuivre cp Pell | souches homéopathiques | Boiron-France |
56 | 08/06/2023 | 6883281 | Oligostim Zinc Cuivre cp | souches homéopathiques | Boiron-France |
48 | 15/06/2023 | 5703011 | Pepsane gel buvable sn sachet dosqe 10 gr | Mayoly splindler | |
49 | 15/06/2023 | 5910011 | Baume Aroma Crème | Mayoly splindler | |
50 | 15/06/2023 | 5913051 | Megamag Gélules | Mayoly splindler | |
² | 15/06/2023 | 6513042 | xyzall cp B/28 | Levocetirizine | UCB France |
52 | 15/06/2023 | 59130031 | Perubore cp p inh | Mayoly splindler | |
57 | 20/06/2023 | 12693011H | Kogenate FS 250 UI | Bayer | |
58 | 20/06/2023 | 12693012H | Kogenate FS 500 UI | Bayer | |
59 | 20/06/2023 | 12693013H | Kogenate FS 1000 UI | Bayer | |
60 | 20/06/2023 | 12853011 | ULTRAVIST 300 B/10 FL /20 ml | Bayer | |
61 | 14/07/2023 | 6353012 | Coversyl 4 mg cp séc | Perindopril | Servier |
62 | 14/07/2023 | 6353131 | Bipreterax 4/1.25 mg cp | perindopril/indapamide) | Servier |
63 | 14/07/2023 | 6353151 | Coversyl 8 mg cp séc | Perindopril | Servier |
66 | 17/07/2023 | Bétadine 10% Vaginale FL/125 ML | PVPI | Mudipharma | |
67 | 17/07/2023 | Betadine Gel der t30 g | PVPI | Mudipharma | |
68 | 17/07/2023 | Bétadine Scrub 4% FL/500 ML | PVPI | Mudipharma | |
69 | 17/07/2023 | Bétadine Scrub 4% FL/125 ML | PVPI | Mudipharma | |
70 | 17/07/2023 | Bétadine Dermique FL/125 ML | PVPI | Mudipharma | |
71 | 17/07/2023 | Bétadine sol bucc 10% FL/125 ML | PVPI | Mudipharma | |
64 | 24/07/2023 | 11073071 | Repaglinid Sandoz 0.5 mg cp b/90 | Repaglinide | Sandoz GMBH |
65 | 24/07/2023 | 11073072 | Repaglinid Sandoz 1 mg cp b/90 | Repaglinide | Sandoz GMBH |
72 | 24/07/2023 | 11073073 | Repaglinid Sandoz 2 mg cp b/90 | Repaglinide | Sandoz GMBH |
73 | 24/07/2023 | 11073063 | venlafaxin Sandoz 150 mg cp b/30 | Venlafaxine | Sandoz GMBH |
74 | 03/08/2023 | COSOPT COLLYRE FL/5ML | dorzol | ||
74 | 14/08/2023 | 10283421H | JADENU 90 mg cp pel B90 | NOVARTIS | |
75 | 14/08/2023 | 10283422H | JADENU 180 mg cp pel B90 | NOVARTIS | |
76 | 14/08/2023 | 10283423H | JADENU 360 mg cp pel B90 | NOVARTIS | |
77 | 15/08/2023 | 11073041H | SKIAKOL COLLYRE FL/0.5 ML | NOVARTIS | |
78 | 04/09/2023 | 11073041H | ceftazidime sandoz 1 g ppinj b/10 fl | ceftazidime | Sandoz GMBH |
79 | 04/09/2023 | 11073034 | Quétiapine Sandoz 25 mg cp b/60 | Quétiapine | Sandoz GMBH |
80 | 04/09/2023 | 11073033 | Quétiapine Sandoz 100 mg cp b/60 | Quétiapine | Sandoz GMBH |
81 | 04/09/2023 | 11073032 | Quétiapine Sandoz 200 mg cp b/60 | Quétiapine | Sandoz GMBH |
82 | 04/09/2023 | 11073031 | Quétiapine Sandoz 300 mg cp b/60 | Quétiapine | Sandoz GMBH |
83 | 04/09/2023 | 6243181 | Montelukast Sandoz 10 mg cp b/28 | Montelukast | Sandoz GMBH |
84 | 04/09/2023 | 6243141 | Mitazapine Sandoz 15 mg cp B30 | ||
85 | 11/09/2023 | 6210013 | COLIMYCINE 1000000UI PPINJ B/50 | Colistine | SANOFI AVENTIS France |
86 | 11/09/2023 | 3463011 | arava 10 mg cp fl/30 | SANOFI deutschland | |
87 | 11/09/2023 | 6213038 | lovenox 4000 b/6 seri | enoxaparine | SANOFI AVENTIS France |
88 | 11/09/2023 | 62130310 | lovenox 8000 b/10 seri | enoxaparine | SANOFI AVENTIS France |
89 | 11/09/2023 | 6213039 | lovenox 6000 b/10 seri | enoxaparine | SANOFI AVENTIS France |
90 | 11/09/2023 | 6213037 | lovenox 2000 b/6seri | enoxaparine | SANOFI AVENTIS France |
91 | 11/09/2023 | 6213037 | lovenox 2000 b/6seri | enoxaparine | SANOFI AVENTIS France |
92 | 11/09/2023 | 5660062 | Lasilix Retard gel lp B30 | FUROSEMIDE | SANOFI AVENTIS France |
93 | 15/09/2023 | 10283224H | EXCELON PATCH DTD 4.6/24H B/30 | Rivastigùiner | NOVARTIS |
94 | 15/09/2023 | 10283225H | EXCELON PATCH DTD 9.5/24H B/30 | Rivastigmine | NOVARTIS |
95 | 15/09/2023 | 10283221H | EXCELON PATCH DTD 9.5/24H B/60 | Rivastigmine | NOVARTIS |
96 | 19/09/2023 | 7273041 | HYDROCORTISONE UPJOHN 100 mg inj B/1 | Hydrocortisone | NAPP |
97 | 20/09/2023 | 16263021 | oxynorm 5 mg gel | oxycodone | NAPP |
98 | 20/09/2023 | 16263022 | oxynorm 10 mg gel | oxycodone | NAPP |
99 | 20/09/2023 | 16263023 | oxynorm 20 mg gel | oxycodone | NAPP |
100 | 11/10/2023 | 6653561H | LEFFTARA 2.5 MG CP B30 | LETROZOLE | NAPP |
101 | 11/10/2023 | 6653561H | MIDAZOLAM 5mg/4ml B/10 | MIDAZOLAM | Hikma |
102 | 11/10/2023 | 6653441 | Rolan 50mg/2ml IV/IM AP B5 | RANITIDINE | Hikma |
103 | 25/10/2023 | 10283272H | Tasigna 150 mg | Nilotinib | NOVARTIS |
105 | 25/10/2023 | 10283272H | Tasigna 150 mg | Nilotinib | NOVARTIS |
108 | 25/10/2023 | 6943062 | EBEFEN 20 MG CP B30 | TAMOXIFENE | Sandoz GMBH |
104 | 25/10/2023 | Montelukast Sandoz 5 mg cp b/28 | Montelukast | Sandoz GMBH | |
106 | 25/10/2023 | 11073051H | PIPERACILLINE TAZOBACTAM 4/500 MG PPINJ | PITERACILLINE/TAZOBACTAM | Sandoz GMBH |
107 | 25/10/2023 | 11073062 | venlafaxin Sandoz 75 mg cp b/30 | Venlafaxine | Sandoz GMBH |
109 | 25/10/2023 | 6943191H | neoflubin 50mg/2ml sol inj B/1 FL | FLUDARABINE | Sandoz GMBH |
110 | 25/10/2023 | 6943052H | DOXORUBICIN 50mg/25ml Sol PPerf B1FL | Doxorubicine | Sandoz GMBH |
111 | 25/10/2023 | FEMARA 2.5 mg CP B30 | LETROZOLE | NOVARTID | |
112 | 31/10/2023 | 84833011 | Strattera 10 mg Gélule B28 | ATOMOXETINE | ELLY LILLY |
113 | 31/10/2023 | 84833012 | Strattera 18 mg Gélule B28 | ATOMOXETINE | |
114 | 31/10/2023 | 84833013 | Strattera 25 mg Gélule B28 | ATOMOXETINE | |
115 | 31/10/2023 | 84833014 | Strattera 40 mg Gélule B28 | ATOMOXETINE | |
116 | 31/10/2023 | 84833015 | Strattera 60 mg Gélule B28 | ATOMOXETINE | |
117 | 02/11/2023 | Drill Miel Rosat Pastille B24 | Pierre Fabre France | ||
118 | 03/11/2023 | 6653202 | PRAZIN 0.5 mg cp B/30 | Alprazolam | Hikma |
120 | 22/11/2023 | 15303031 | Cyproterone Acetate Stragen 50 mg comp B/56 | Cyprotérone | STRAGEN UK |
119 | 22/11/2023 | 15303012H | PITERACILLINE/TAZOBACTAM PPINJ B/1FL | PITERACILLINE/TAZOBACTAM | STRAGEN UK |
121 | 23/11/2023 | 10283141 | MIFLONIDE BREEZHALER PPINH 200 mg | BUDESONIDE | NOVARTIS |
122 | 23/11/2023 | 10283142 | MIFLONIDE BREEZHALER PPINH 400 mg | BUDESONIDE | NOVARTIS |
123 | 08/12/2023 | 10803014H | CAMPTO 20 mg/ml (100mg) Solution injectable pour perfusion | IRINOTECAN | PFIZER HOLDING FRANCE |
124 | 08/12/2023 | 10803013H | CAMPTO 20 mg/ml (40mg) Solution injectable pour perfusion | IRINOTECAN | PFIZER HOLDING FRANCE |
125 | 08/12/2023 | 8013053H | VFEND 200 mg Comprimé pelliculé | VORICONAZOLE | PFIZER Europe MA EEIG |
126 | 08/12/2023 | 8013052H | VFEND 50 mg Comprimé pelliculé | VORICONAZOLE | PFIZER Europe MA EEIG |
127 | 08/12/2023 | 8013021 | ZITROMAX 600 MG 40 MG/ML Powder for oral solution | AZITHROMYCINE | PFIZER SA Belgique |
128 | 08/12/2023 | 8013022 | ZITROMAX 900 MG 40 MG/ML Powder for oral solution | AZITHROMYCINE | PFIZER SA BELGIQUE |
129 | 08/12/2023 | 11413014H | DBL IRINOTECAN 100 MG/5ML Solution injectable pour perfusion | IRINOTECAN | HOSPIRA AUSTRALIA PTY |
130 | 08/12/2023 | 13613061H | IRINOTECAN HOSPIRA40 mg /2 ml Solution injectable pour perfusion | IRINOTECAN | HOSPIRA UK Ltd |
131 | 08/12/2023 | Lucentis 10mg/ml sol inj NB | RANIBUZIMAB | NOVARTIS | |
132 | 11/12/2023 | 5983042 | Klean prep POS B2 | Norgine PHARMA | |
133 | 11/12/2023 | 5983041 | Klean prep POS B4 | Norgine PHARMA | |
134 | 11/12/2023 | 5983021 | Normacol lavement adulte | Norgine PHARMA | |
135 | 11/12/2023 | 5983023 | Normacol lavement enfant | Norgine PHARMA | |
136 | 11/12/2023 | 5983024 | Normacol 62g/100 ggranules lp | Norgine PHARMA | |
137 | 11/12/2023 | 5983081 | MOVICOL 13.8 G poudre en sachet |
* Demande d'annulation d'enregsitrement
N° | Date | N° AMM | Libellé | DCI | Titulaire |
1 | 19/01/2023 | AMM en instance | Lemtrada 13 mg So Inj P PERF B/1 FL /1.2 ml | Alemtuzumab | Genzyme thetrapeutics LTD |
2 | 19/01/2023 | AMM en instance | Jevtana 60 mg sol inj P PERF B/1 | ABAZITAXEL | SANOFI AVENTIS GROUPE |
3 | 25/12/2020 | AMM en instance | Signifor 0.3 mg/ml sol inj B/30 AP | ||
4 | 25/12/2020 | AMM en instance | Signifor 0.6 mg/ml sol inj B/30 AP | ||
5 | 25/12/2020 | AMM en instance | Signifor 0.6 mg/ml sol inj B/30 AP | ||
6 | 20/04/2023 | AMM en instance | Folotyn 20 mg/3l | Pralatrexate | Mundipharma SAS |
7 | 10/05/2023 | AMM en instance | Oprevo GTTES buv B/10FL/20 ML | VACCIN POLIO | Sanofi Pasteutr |
8 | 26/05/2023 | AMM en instance | flutiform 125µg/5µg susp p inh | fluticasone+formoterol | Napp Pharmaceuticals ltd |
9 | 26/05/2023 | AMM en instance | flutiform 250µg/5µg susp p inh | fluticasone+formoterol | Napp Pharmaceuticals ltd |
10 | 26/05/2023 | AMM en instance | flutiform 50µg/5µg susp p inh | fluticasone+formoterol | Napp Pharmaceuticals ltd |
11 | 06/06/2023 | AMM en instance | GIOTRIF 30 mg cp B28 | Boehringer-Allemagne | |
12 | 06/06/2023 | AMM en instance | GIOTRIF 40 mg cp B28 | Boehringer-Allemagne | |
13 | 06/06/2023 | AMM en instance | GIOTRIF 50 mg cp B28 | Boehringer-Allemagne | |
14 | 06/06/2023 | AMM en instance | GIOTRIF 20 mg cp B28 | Boehringer-Allemagne | |
15 | 24/08/2023 | AMM en instance | cosentyx unoready 300 mg inj | novartis | |
16 | 29/08/2023 | AMM en instance | EnERZAIIR BREEZHALER PDRE inh b/30 | GlYCOPYRRONIUM INDACATEROL MOMETASONE B30+INH | novartis |
17 | 30/08/2023 | AMM en instance | atectura BREEZHALER 125/127.5 PDRE inh b/30 | INDACATEROL MOMETASONE B30+INH | novartis |
18 | 30/08/2023 | AMM en instance | atectura BREEZHALER 125/260 PDRE inh b/30 | INDACATEROL MOMETASONE B30+INH | novartis |
19 | 14/09/2023 | AMM en instance | TIVICAY CP | VIV | |
20 | 14/09/2023 | AMM en instance | KIVEXA CP | VIV | |
21 | 19/09/2023 | AMM en instance | oxynorm 10 mg inj | oxycodone | Napp Pharmaceuticals ltd |
22 | 20/09/2023 | AMM en instance | oxynorm 20 mg inj | oxycodone | Napp Pharmaceuticals ltd |
23 | 19/09/2023 | AMM en instance | oxycontin 10 mg cp lp | oxycodone | Napp Pharmaceuticals ltd |
24 | 19/09/2023 | AMM en instance | oxycontin 15 mg cp lp | oxycodone | Napp Pharmaceuticals ltd |
25 | 19/09/2023 | AMM en instance | oxycontin 20 mg cp lp | oxycodone | Napp Pharmaceuticals ltd |
26 | 19/09/2023 | AMM en instance | oxycontin 30 mg cp lp | oxycodone | Napp Pharmaceuticals ltd |
27 | 19/09/2023 | AMM en instance | oxycontin 40 mg cp lp | oxycodone | Napp Pharmaceuticals ltd |
28 | 19/09/2023 | AMM en instance | oxycontin 60 mg cp lp | oxycodone | Napp Pharmaceuticals ltd |
29 | 19/09/2023 | AMM en instance | oxycontin 80 mg cp lp | oxycodone | Napp Pharmaceuticals ltd |
30 | 19/09/2023 | AMM en instance | Targinact 10/5 mg cp lp | oxycodone/naloxone | Napp Pharmaceuticals ltd |
31 | 19/09/2023 | AMM en instance | Targinact 20/10 mg cp lp | oxycodone/naloxone | Napp Pharmaceuticals ltd |
32 | 19/09/2023 | AMM en instance | Targinact 40/20 mg cp lp | oxycodone/naloxone | Napp Pharmaceuticals ltd |
33 | 19/09/2023 | AMM en instance | Butrans 5µg/H DTD | BUPRENORPHINE | Napp Pharmaceuticals ltd |
34 | 19/09/2023 | AMM en instance | Butrans 10µg/H DTD | BUPRENORPHINE | Napp Pharmaceuticals ltd |
35 | 19/09/2023 | AMM en instance | Butrans 20µg/H DTD | BUPRENORPHINE | Napp Pharmaceuticals ltd |
36 | 24/10/2023 | AMM en instance | HUMIRA 80 MG SOL INJ STYLO Pré-remplie B/1 | ADALIMUMAB | ABBVIE |
37 | 24/10/2023 | AMM en instance | HUMIRA 40 MG SOL INJ STYLO Pré-remplie B/1 | ADALIMUMAB | ABBVIE |
38 | 31/10/2031 | AMM en instance | Trulicity 0.75 Mg/0.5 Ml Soin Styl B/4 Stylo Pré-Rempli | Dulaglutide | Elly Lilly |
39 | 31/10/2031 | AMM en instance | Trulicity1.5 Mg/0.5 Ml Soin Styl B/4 Stylo Pré-Rempli | Dulaglutide | Elly Lilly |
40 | 31/10/2031 | AMM en instance | Olumiant4 Mg Cope B/28 | Baricitunib | Elly Lilly |
41 | 31/10/2031 | AMM en instance | Olumiant 2 Mg Cope Plaq B/28 | Baricitunib | Elly Lilly |
42 | 31/10/2031 | AMM en instance | Taltz 80 Mg/Ml Soin Seri B/1 | Ixekizumab | Elly Lilly |
43 | 31/10/2031 | AMM en instance | Cyramza 10 Mg/Ml Soldp Flac B/1fl/50ml | Ramucirumab | Elly Lilly |
44 | 31/10/2031 | AMM en instance | Cyramza 10 Mg/Ml Soldp Flac B/1fl/10ml | Ramucirumab | Elly Lilly |
45 | 31/10/2031 | AMM en instance | Verzenios 150 Mg Cope Blis B/56 | Abemaciclib | Elly Lilly |
46 | 31/10/2031 | AMM en instance | Verzenios 100 Mg Cope Blis B/56 | Abemaciclib | Elly Lilly |
47 | 31/10/2031 | AMM en instance | Verzenios 50 Mg Cope Blis B/56 | Abemaciclib | Elly Lilly |
48 | 23/11/2023 | AMM en instance | BEOVU SOL INJ 120 MG/ML | BROLUCIZUMAB | NOVARTIS |
49 | 23/11/2023 | AMM en instance | piqray 200 mg CP Pell B28 | ALPELISIB | NOVARTIS |
50 | 23/11/2023 | AMM en instance | piqray 150 mg CP Pell B56 | ALPELISIB | NOVARTIS |
51 | 23/11/2023 | AMM en instance | piqray 200 mg +50 MGCP Pell B28+28 | ALPELISIB | NOVARTIS |
52 | 04/12/2023 | AMM en instance | Skyrizi 75 mg inj en ser pré-remplie | Rizankizumab | Abbvie |
53 | 07/12/2023 | AMM en instance | Abstral 100 µg cp Sblingual b10 | Fentanyl | KWYA Kirinn INC |
54 | 07/12/2023 | AMM en instance | Abstral 200 µg cp Sblingual b11 | Fentanyl | KWYA Kirinn INC |
55 | 07/12/2023 | AMM en instance | Abstral 400 µg cp Sblingual b12 | Fentanyl | KWYA Kirinn INC |